105 related articles for article (PubMed ID: 22068655)
1. MAGE: the spell is broken.
Rezvani K
Clin Cancer Res; 2011 Nov; 17(22):6955-7. PubMed ID: 22068655
[TBL] [Abstract][Full Text] [Related]
2. Improving T-cell therapy for relapsed EBV-negative Hodgkin lymphoma by targeting upregulated MAGE-A4.
Cruz CR; Gerdemann U; Leen AM; Shafer JA; Ku S; Tzou B; Horton TM; Sheehan A; Copeland A; Younes A; Rooney CM; Heslop HE; Bollard CM
Clin Cancer Res; 2011 Nov; 17(22):7058-66. PubMed ID: 21908573
[TBL] [Abstract][Full Text] [Related]
3. DNA methyltransferase inhibition increases efficacy of adoptive cellular immunotherapy of murine breast cancer.
Terracina KP; Graham LJ; Payne KK; Manjili MH; Baek A; Damle SR; Bear HD
Cancer Immunol Immunother; 2016 Sep; 65(9):1061-73. PubMed ID: 27416831
[TBL] [Abstract][Full Text] [Related]
4. Decitabine enhances tumor recognition by T cells through upregulating the MAGE-A3 expression in esophageal carcinoma.
Shi X; Chen X; Fang B; Ping Y; Qin G; Yue D; Li F; Yang S; Zhang Y
Biomed Pharmacother; 2019 Apr; 112():108632. PubMed ID: 30797153
[TBL] [Abstract][Full Text] [Related]
5. Induction of a specific CD8+ T-cell response to cancer/testis antigens by demethylating pre-treatment against osteosarcoma.
Li B; Zhu X; Sun L; Yuan L; Zhang J; Li H; Ye Z
Oncotarget; 2014 Nov; 5(21):10791-802. PubMed ID: 25301731
[TBL] [Abstract][Full Text] [Related]
6. Low-dose decitabine induces MAGE-A expression and inhibits invasion via suppression of NF-κB2 and MMP2 in Eca109 cells.
Liu WH; Sang MX; Hou SY; Zhang C; Shan BE
Biomed Pharmacother; 2014 Jul; 68(6):745-50. PubMed ID: 25123082
[TBL] [Abstract][Full Text] [Related]
7. Hypertonicity induction of melanoma antigen, a tumor-associated antigen.
Park JH; Lee SW
Mol Cells; 2002 Apr; 13(2):288-95. PubMed ID: 12018852
[TBL] [Abstract][Full Text] [Related]
8. Expansion of cancer germline antigen-specific cytotoxic T lymphocytes for immunotherapy.
Krishnadas DK; Wang Y; Sundaram K; Bai F; Lucas KG
Tumour Biol; 2017 Jul; 39(7):1010428317701309. PubMed ID: 28677424
[TBL] [Abstract][Full Text] [Related]
9. Decitabine facilitates immune recognition of sarcoma cells by upregulating CT antigens, MHC molecules, and ICAM-1.
Krishnadas DK; Bao L; Bai F; Chencheri SC; Lucas K
Tumour Biol; 2014 Jun; 35(6):5753-62. PubMed ID: 24584817
[TBL] [Abstract][Full Text] [Related]
10. Targeting the MAGE A3 antigen in pancreatic cancer.
Cogdill AP; Frederick DT; Cooper ZA; Garber HR; Ferrone CR; Fiedler A; Rosenberg L; Thayer SP; Warshaw AL; Wargo JA
Surgery; 2012 Sep; 152(3 Suppl 1):S13-8. PubMed ID: 22770803
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic and functional changes of human melanoma xenografts induced by DNA hypomethylation: immunotherapeutic implications.
Coral S; Sigalotti L; Colizzi F; Spessotto A; Nardi G; Cortini E; Pezzani L; Fratta E; Fonsatti E; Di Giacomo AM; Nicotra MR; Natali PG; Altomonte M; Maio M
J Cell Physiol; 2006 Apr; 207(1):58-66. PubMed ID: 16252259
[TBL] [Abstract][Full Text] [Related]
12. Induction of MAGE-3 expression in lung and esophageal cancer cells.
Weiser TS; Ohnmacht GA; Guo ZS; Fischette MR; Chen GA; Hong JA; Nguyen DM; Schrump DS
Ann Thorac Surg; 2001 Jan; 71(1):295-301; discussion 301-2. PubMed ID: 11216765
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of systemic adoptive transfer immunotherapy targeting NY-ESO-1 for glioblastoma.
Everson RG; Antonios JP; Lisiero DN; Soto H; Scharnweber R; Garrett MC; Yong WH; Li N; Li G; Kruse CA; Liau LM; Prins RM
Neuro Oncol; 2016 Mar; 18(3):368-78. PubMed ID: 26330563
[TBL] [Abstract][Full Text] [Related]
14. Demethylating agent decitabine induces autologous cancer testis antigen specific cytotoxic T lymphocytes in vivo.
Zhou JH; Yao YS; Wang LX; Wang J; Li YH; Jiang MM; Zhou MH; Gao XN; Li RS; Wang LL; Yu L
Chin Med J (Engl); 2013 Dec; 126(23):4552-6. PubMed ID: 24286424
[TBL] [Abstract][Full Text] [Related]
15. De novo induction of a cancer/testis antigen by 5-aza-2'-deoxycytidine augments adoptive immunotherapy in a murine tumor model.
Guo ZS; Hong JA; Irvine KR; Chen GA; Spiess PJ; Liu Y; Zeng G; Wunderlich JR; Nguyen DM; Restifo NP; Schrump DS
Cancer Res; 2006 Jan; 66(2):1105-13. PubMed ID: 16424047
[TBL] [Abstract][Full Text] [Related]
16. Expression of MAGE and BAGE genes in Japanese breast cancers.
Fujie T; Mori M; Ueo H; Sugimachi K; Akiyoshi T
Ann Oncol; 1997 Apr; 8(4):369-72. PubMed ID: 9209667
[TBL] [Abstract][Full Text] [Related]
17. Zebularine Treatment Induces MAGE-A11 Expression and Improves CTL Cytotoxicity Using a Novel Identified HLA-A2-restricted MAGE-A11 Peptide.
Zhang J; Sang M; Gu L; Liu F; Li W; Yin D; Wu Y; Liu S; Huang W; Shan B
J Immunother; 2017; 40(6):211-220. PubMed ID: 28486273
[TBL] [Abstract][Full Text] [Related]
18. Expressions of MAGE-A9 and MAGE-A11 in breast cancer and their expression mechanism.
Hou SY; Sang MX; Geng CZ; Liu WH; Lü WH; Xu YY; Shan BE
Arch Med Res; 2014 Jan; 45(1):44-51. PubMed ID: 24316396
[TBL] [Abstract][Full Text] [Related]
19. Decitabine facilitates the generation and immunosuppressive function of regulatory γδT cells derived from human peripheral blood mononuclear cells.
Hu Y; Cui Q; Gu Y; Sheng L; Wu K; Shi J; Tan Y; Fu H; Liu L; Fu S; Yu X; Huang H
Leukemia; 2013 Jul; 27(7):1580-5. PubMed ID: 23192015
[No Abstract] [Full Text] [Related]
20. Promoter hypomethylation and reactivation of MAGE-A1 and MAGE-A3 genes in colorectal cancer cell lines and cancer tissues.
Kim KH; Choi JS; Kim IJ; Ku JL; Park JG
World J Gastroenterol; 2006 Sep; 12(35):5651-7. PubMed ID: 17007017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
